» Articles » PMID: 32224828

Circulating Neurofilament Light Chain Is Associated With Survival After Pediatric Cardiac Arrest

Overview
Specialty Pediatrics
Date 2020 Apr 1
PMID 32224828
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To characterize neurofilament light levels in children who achieved return of spontaneous circulation following cardiac arrest compared with healthy controls and determine an association between neurofilament light levels and clinical outcomes.

Design: Retrospective cohort study.

Setting: Academic quaternary PICU.

Patients: Children with banked plasma samples from an acute respiratory distress syndrome biomarker study who achieved return of spontaneous circulation after a cardiac arrest and healthy controls.

Interventions: None.

Measurements And Main Results: Neurofilament light levels were determined with a highly sensitive single molecule array digital immunoassay. Patients were categorized into survivors and nonsurvivors and into favorable (Pediatric Cerebral Performance Category score of 1-2 or unchanged from baseline) or unfavorable (Pediatric Cerebral Performance Category score of 3-6 or Pediatric Cerebral Performance Category score change ≥1 from baseline). Associations between neurofilament light level and outcomes were determined using Wilcoxon rank-sum test. We enrolled 32 patients with cardiac arrest and 18 healthy controls. Demographics, severity of illness, and baseline Pediatric Cerebral Performance Category scores were similar between survivors and nonsurvivors. Healthy controls had lower median neurofilament light levels than patients after cardiac arrest (5.5 [interquartile range 5.0-8.2] vs 31.0 [12.0-338.6]; p < 0.001). Neurofilament light levels were higher in nonsurvivors than survivors (78.5 [26.2-509.1] vs 12.4 [10.3-28.2]; p = 0.012) and higher in survivors than healthy controls (p = 0.009). The four patients who survived with a favorable outcome had neurofilament light levels that were not different from patients with unfavorable outcomes (21.9 [8.5--35.7] vs 37.2 [15.4-419.1]; p = 0.60) although two of the four patients who survived with favorable outcomes had progressive encephalopathies with both baseline and postcardiac arrest Pediatric Cerebral Performance Category scores of 4.

Conclusions: Neurofilament light is a blood biomarker of hypoxic-ischemic brain injury and may help predict survival and neurologic outcome after pediatric cardiac arrest. Further study in a larger, dedicated cardiac arrest cohort with serial longitudinal measurements is warranted.

Citing Articles

Elevated serum neurologic biomarker profiles after cardiac arrest in a porcine model.

Senthil K, Ranganathan A, Piel S, Hefti M, Reeder R, Kirschen M Resusc Plus. 2024; 19:100726.

PMID: 39149222 PMC: 11325790. DOI: 10.1016/j.resplu.2024.100726.


Brain injury plasma biomarkers in patients on veno-arterial extracorporeal membrane oxygenation: A pilot prospective observational study.

Ahmad S, Kapoor S, Muquit S, Gusdon A, Khanduja S, Ziai W Perfusion. 2024; :2676591241256006.

PMID: 38757156 PMC: 11569265. DOI: 10.1177/02676591241256006.


Neurofilaments as biomarkers in neurological disorders - towards clinical application.

Khalil M, Teunissen C, Lehmann S, Otto M, Piehl F, Ziemssen T Nat Rev Neurol. 2024; 20(5):269-287.

PMID: 38609644 DOI: 10.1038/s41582-024-00955-x.


Higher levels of brain injury biomarker tau are associated with unfavorable outcomes in patients supported with ECMO following cardiac arrest.

McElrath Schwartz J, Ng D, Roem J, Padmanabhan N, Romero D, Joe J Resusc Plus. 2024; 18:100609.

PMID: 38549693 PMC: 10973722. DOI: 10.1016/j.resplu.2024.100609.


2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support;....

Berg K, Bray J, Ng K, Liley H, Greif R, Carlson J Circulation. 2023; 148(24):e187-e280.

PMID: 37942682 PMC: 10713008. DOI: 10.1161/CIR.0000000000001179.


References
1.
Rosen C, Rosen H, Andreasson U, Bremell D, Bremler R, Hagberg L . Cerebrospinal fluid biomarkers in cardiac arrest survivors. Resuscitation. 2013; 85(2):227-32. DOI: 10.1016/j.resuscitation.2013.10.032. View

2.
Rana O, Schroder J, Baukloh J, Saygili E, Mischke K, Schiefer J . Neurofilament light chain as an early and sensitive predictor of long-term neurological outcome in patients after cardiac arrest. Int J Cardiol. 2013; 168(2):1322-7. DOI: 10.1016/j.ijcard.2012.12.016. View

3.
Shahim P, Gren M, Liman V, Andreasson U, Norgren N, Tegner Y . Serum neurofilament light protein predicts clinical outcome in traumatic brain injury. Sci Rep. 2016; 6:36791. PMC: 5098187. DOI: 10.1038/srep36791. View

4.
Rissin D, Fournier D, Piech T, Kan C, Campbell T, Song L . Simultaneous detection of single molecules and singulated ensembles of molecules enables immunoassays with broad dynamic range. Anal Chem. 2011; 83(6):2279-85. PMC: 3056883. DOI: 10.1021/ac103161b. View

5.
Rundgren M, Friberg H, Cronberg T, Romner B, Petzold A . Serial soluble neurofilament heavy chain in plasma as a marker of brain injury after cardiac arrest. Crit Care. 2012; 16(2):R45. PMC: 3681370. DOI: 10.1186/cc11244. View